CpG or IFN-α are more potent adjuvants than GM-CSF to promote anti-tumor immunity following idiotype vaccine in multiple myeloma
about
Immunogenic targets for specific immunotherapy in multiple myelomaImmunomodulatory effect of DC/CIK combined with chemotherapy in multiple myeloma and the clinical efficacy.Idiotypes as immunogens: facing the challenge of inducing strong therapeutic immune responses against the variable region of immunoglobulinsEnhancement of humoral and cell mediated immune response to HPV16 L1-derived peptides subsequent to vaccination with prophylactic bivalent HPV L1 virus-like particle vaccine in healthy females.Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccine.Tumor-altered dendritic cell function: implications for anti-tumor immunity.Prospect and progress of personalized peptide vaccinations for advanced cancers.Construction and immunogenicity of DNA vaccines encoding fusion protein of porcine IFN- λ 1 and GP5 gene of porcine reproductive and respiratory syndrome virus.
P2860
Q26859007-DCFFE3D6-BBF8-47D5-9AD5-437BF985C241Q36375348-6DEBCF00-45FC-4284-B181-00AC1DB2D9E9Q36386109-F5B9DF97-F86D-4E48-AC8A-DD88328DE882Q37735000-F6BE2DFE-B4A5-4485-ADB7-D9D484E252A8Q38063819-31E5E43F-8AB6-46A8-8252-6B727C0D9A6FQ38123166-4E81359E-EC93-4162-B6B7-DE5CA2C05875Q38758988-EA89CC21-0D42-4AC4-A171-CB8883489EF9Q44781644-2F4625F4-D61B-4B38-B987-734143456043
P2860
CpG or IFN-α are more potent adjuvants than GM-CSF to promote anti-tumor immunity following idiotype vaccine in multiple myeloma
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 October 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CpG or IFN-α are more potent a ...... pe vaccine in multiple myeloma
@en
CpG or IFN-α are more potent a ...... e vaccine in multiple myeloma.
@nl
type
label
CpG or IFN-α are more potent a ...... pe vaccine in multiple myeloma
@en
CpG or IFN-α are more potent a ...... e vaccine in multiple myeloma.
@nl
prefLabel
CpG or IFN-α are more potent a ...... pe vaccine in multiple myeloma
@en
CpG or IFN-α are more potent a ...... e vaccine in multiple myeloma.
@nl
P2093
P2860
P1476
CpG or IFN-α are more potent a ...... pe vaccine in multiple myeloma
@en
P2093
Jianfei Qian
Sungyoul Hong
Yuhuan Zheng
P2860
P2888
P304
P356
10.1007/S00262-011-1123-2
P577
2011-10-15T00:00:00Z